- Sony Biotechnology
- Sony Biotechnology
Sony Biotechnology is closely monitoring the COVID-19 situation across the globe. Our first priority is to ensure the health and safety of our employees in affected areas around the world. We are reviewing guidance from the World Health Organization (WHO), US Centers for Disease Control and Prevention (CDC), government agencies, and health officials in a variety of affected countries.
Learn about the mechanism of the adaptive immune response generated in severe cases of COVID-19 and the role played by TGF-β in the chronic immune reaction.
Learn how cell sorting and ResolveDNA™ technologies can be used in a workflow to interrogate genomic heterogeneity in diverse types of tumors
Understand how to utilize cryopreserved primary solid tissues to accelerate preclinical pipelines.
Join this educational webinar to learn about the key aspects of sorting that should be considered to ensure optimal cell sorting results for different applications.
Cardiopulmonary diseases represent a significant health burden for many countries around the world. It is therefore vital to accelerate research toward the development of new therapies to treat these diseases. In this article, we talk to researchers at Queen’s University, Ontario, Canada, about the new Queen’s CardioPulmonary Unit (QCPU) core facility and research center, and how studying endothelial dysfunction, mitochondrial biology, and specific gene mutations is improving the understanding of the molecular factors influencing diseases of the lung vasculature, such as pulmonary arterial hypertension (PAH).
Gain insights on how PSCs can be used to study cardiac development and disease.
Explore approaches that integrate different single-cell analysis technologies for immune cell profiling and learn how large data sets generated across various platforms can be combined to study multidimensional biology.
In their quest for answers, Dr. Moshe Sade-Feldman’s team at the Translational Cancer Immunology (TCI) laboratory at Massachusetts General Hospital (MGH), analyzes real-life data from patients treated with immunotherapies. Learn how the team used single-cell profiling to probe the role played by immune cells in patient tumors in the development of the response to cancer therapy.
Discover how flow cytometry, single cell RNA sequencing, and multispectral imaging can be used together to identify key biomarkers in lung cancer immune response.